Arricau-Bouvery et al., 2005 - Google Patents
Effect of vaccination with phase I and phase II Coxiella burnetii vaccines in pregnant goatsArricau-Bouvery et al., 2005
- Document ID
- 6622137224370023737
- Author
- Arricau-Bouvery N
- Souriau A
- Bodier C
- Dufour P
- Rousset E
- Rodolakis A
- Publication year
- Publication venue
- Vaccine
External Links
Snippet
Livestock is considered to be the major “source” of human Q fever. The efficacy of two currently available vaccines (Coxevac, phase I, CEVA Santé Animale and Chlamyvax FQ, phase II, MERIAL) against Coxiella excretion was investigated in terms of risks to human …
- 241000283707 Capra 0 title abstract description 112
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Arricau-Bouvery et al. | Effect of vaccination with phase I and phase II Coxiella burnetii vaccines in pregnant goats | |
| Bouvery et al. | Experimental Coxiella burnetii infection in pregnant goats: excretion routes | |
| Van den Brom et al. | Coxiella burnetii infections in sheep or goats: an opinionated review | |
| Angelakis et al. | Q fever | |
| Arricau-Bouvery et al. | Is Q fever an emerging or re-emerging zoonosis? | |
| Stein et al. | Pigeon pneumonia in provence: a bird-borne Q fever outbreak | |
| Woldehiwet | Q fever (coxiellosis): epidemiology and pathogenesis | |
| Astobiza et al. | Coxiella burnetii shedding and environmental contamination at lambing in two highly naturally-infected dairy sheep flocks after vaccination | |
| Porter et al. | Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis | |
| Serbezov et al. | Q fever in Bulgaria and Slovakia. | |
| Bhanuprakash et al. | Prospects of control and eradication of capripox from the Indian subcontinent: A perspective | |
| Veronesi et al. | Live attenuated bluetongue vaccine viruses in Dorset Poll sheep, before and after passage in vector midges (Diptera: Ceratopogonidae) | |
| Rodolakis | Q fever, state of art: Epidemiology, diagnosis and prophylaxis | |
| Rodning et al. | Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus | |
| Barnett et al. | Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the ‘carrier’state in sheep | |
| Maresch et al. | Oral immunization of wild boar and domestic pigs with attenuated live vaccine protects against Pseudorabies virus infection | |
| Eibach et al. | Q fever: baseline monitoring of a sheep and a goat flock associated with human infections | |
| Hurisa et al. | A review on sheeppox and goatpox: Insight of epidemiology, diagnosis, treatment and control measures in Ethiopia | |
| Gwida et al. | Q fever: a re-emerging disease | |
| König et al. | Innocuousness and safety of classical swine fever marker vaccine candidate CP7_E2alf in non-target and target species | |
| Falkenberg et al. | Evaluation of bovine viral diarrhea virus transmission potential to naïve calves by direct and indirect exposure routes | |
| Al-Momani et al. | Risk factors associated with Mycoplasma agalactiae infection of small ruminants in northern Jordan | |
| Finlaison et al. | An experimental study of Bungowannah virus infection in weaner aged pigs | |
| Savini et al. | Monovalent modified-live vaccine against bluetongue virus serotype 2: immunity studies in cows | |
| Thompson et al. | Q fever |